Finance

Lists
1733:TPE
Apex Biotechnology Corp
NT$30,80
-0,65%
(-0,20) 1D
11 Sep., 13:30:27 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1733...
Open
NT$30,60
High
NT$30,95
Low
NT$30,60
Mkt. cap
3,08 mjd
Avg. vol.
166,71 k
Volume
67,04 k
Dividend
4,22%
Quarterly dividend
NT$0,32
Ex-dividend date
09 Jun. 2026
P/E ratio
16,30
52-wk high
NT$38,70
52-wk low
NT$28,00
EPS
NT$1,89
Shares outstanding
99,69 m
No. of employees
641
Open
NT$30,60
High
NT$30,95
Low
NT$30,60
Mkt. cap
3,08 mjd
Avg. vol.
166,71 k
Volume
67,04 k
Dividend
4,22%
Quarterly dividend
NT$0,32
Ex-dividend date
09 Jun. 2026
P/E ratio
16,30
52-wk high
NT$38,70
52-wk low
NT$28,00
EPS
NT$1,89
Shares outstanding
99,69 m
No. of employees
641
About Apex Biotechnology Corp
CEO-
Employees641
Founded1997
Headquarters-
SectorMedical device
Websiteapexbio.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
437,21 m
438,99 m
519,72 m
470,65 m
Cost of goods sold
330,39 m
306,63 m
344,06 m
312,37 m
Cost of revenue
330,39 m
306,63 m
344,06 m
312,37 m
Research and development expenses
35,94 m
36,02 m
37,23 m
49,84 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57,27 m
62,79 m
60,29 m
63,81 m
Operating expense
98,80 m
99,12 m
88,45 m
113,66 m
Total operating expenses
429,19 m
405,75 m
432,51 m
426,02 m
Operating income
8,02 m
33,24 m
87,21 m
44,63 m
Other non operating income
775,00 k
894,00 k
191,00 k
591,00 k
EBT including unusual items
29,21 m
58,17 m
86,91 m
44,68 m
EBT excluding unusual items
34,02 m
57,52 m
90,23 m
41,45 m
Income tax expense
7,12 m
7,97 m
5,54 m
7,84 m
Effective tax rate
24,37%
13,70%
6,38%
17,54%
Other operating expenses
-
-
-
-
Net income
22,14 m
50,08 m
81,28 m
36,78 m
Net profit margin
5,06%
11,41%
15,64%
7,81%
Earnings per share
-
-
-
-
Interest and investment income
139,00 k
1,49 m
219,00 k
4,56 m
Interest expense
-835,00 k
-822,00 k
-829,00 k
-804,00 k
Net interest expenses
-696,00 k
665,00 k
-610,00 k
3,75 m
Depreciation and amortization charges
-
-
-
-
EBITDA
20,24 m
45,47 m
99,16 m
56,25 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme